LIPOPROTEINS LABELLING, METHODS FOR TRACKING TRANSPORT/OUTCOME OF LIPOPROTEINS AND FOR DETERMINING DYSLIPIDEMIA DISORDERS

摘要

The invention relates to lipoproteins labelled with a fluorescent analogue of cholesterol, and their use for determining the presence of dyslipidemia disorders in a subject and for tracking in vivo the transport and/or outcome of lipoproteins which naturally comprise cholesterol.